 |
市場調査レポート
商品コード
1540782
細胞分析市場レポート：製品、分析タイプ、エンドユーザー、地域別、2024～2032年Cell Analysis Market Report by Product, Analysis Type, Techniques, End-User, and Region 2024-2032 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。 詳細はお問い合わせください。
| 細胞分析市場レポート：製品、分析タイプ、エンドユーザー、地域別、2024～2032年 |
|
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 136 Pages
納期: 2～3営業日
|
- 全表示
- 概要
- 図表
- 目次
世界の細胞分析市場規模は2023年に207億米ドルに達しました。今後、IMARC Groupは、2024～2032年にかけて7.4%の成長率（CAGR）を示し、2032年までに401億米ドルに達すると予測しています。個別化医療へのシフト、世界のがん患者の増加、細胞分析における人工知能と機械学習の統合の進展などが、市場成長の触媒となっています。
細胞分析市場分析：
主要市場促進要因創薬や薬剤開発、特に腫瘍学や免疫学などのセグメントでの細胞解析ツールに対する需要の高まりが、主に市場成長の原動力となっています。がんや自己免疫疾患のような慢性疾患の有病率の上昇は、疾患診断や治療のための高度な細胞分析技術へのニーズを増大させており、これも市場成長に寄与しています。
主要市場動向：再生医療や幹細胞研究の拡大が、細胞の挙動、分化、治療応用を研究するための細胞分析ツールの必要性を高めており、市場全体に明るい展望をもたらしています。
競合情勢：世界市場で事業を展開している主要な細胞分析企業には、Agilent Technologies Inc.、BD Biosciences、Bio-RAD Laboratories Inc.、Danaher Corporation、Illumina Inc.、Merck KGaA、Miltenyi Biotec、Olympus Corporation、PerkinElmer Inc.、Promega Corporation、Sysmex Corporation、Thermo Fisher Scientificなどがあります。
地理的動向：報告書によると、現在北米が世界市場を独占しています。同地域の成長は、がん罹患率の増加、細胞ベースの研究活動における企業や政府からの資金提供の増加に起因しています。
課題と機会：課題としては、大規模データの解釈の複雑さ、分析中の細胞生存率の維持、先端技術の高コストなどが挙げられます。機会としては、個別化医薬品、再生治療、人工知能の統合による分析能力の向上とプロセスの合理化などにおける応用の拡大が挙げられます。
世界の細胞分析市場動向：
がんの負担増
世界中でがん患者数が増加していることが、主に市場成長の原動力となっています。がん研究における細胞分析ツールや技術は、腫瘍細胞の遺伝子変異、タンパク質発現プロファイル、腫瘍微小環境内での細胞間相互作用など、腫瘍細胞の正確な特性解析を可能にします。がん患者数の増加が細胞分析市場シェアを刺激しています。例えば、米国がん協会（American Cancer Society）の2022年最新情報によると、米国では2022年に約191万8,030人の新規がん患者が発生すると推定されています。さらに、肺がんと乳がんは個人の間で最もよく見られるがんの2つです。カナダがん協会（CCS）によると、2020年には、約2万9,800人のカナダ人が肺がんと診断され、新規がん患者全体の13％を占める。また、約2万1,200人のカナダ人が肺がんで死亡すると予想され、2020年のがん死亡者数の25％を占める。このことは、効果的でより高度ながん細胞分析の必要性が高まっていることを示しています。このように、効果的かつ持続的ながん治療に対する需要の高まりは、市場全体に有利な成長機会をもたらすと予想されます。
新規分子の開発増加
さまざまな感染症の流行は、新規分子やワクチンの開発を促しており、これが細胞分析市場の収益を増大させています。細胞分析ツールは、研究者が潜在的な薬剤候補の有効性、安全性、作用機序を評価できるようにすることで、創薬開発において重要な役割を果たしています。さらに、様々な製薬会社やバイオテクノロジー企業は、新薬や改良薬を導入するために細胞分析技術やツールへの依存度を高めています。例えば、米国議会予算局が発表したデータによると、2021年、製薬業界は2020年の研究開発に世界全体で約2,000億米ドルを費やしたのに対し、2019年には8,300万米ドルを費やしたことが確認されています。同様に、Danaher Corporationは、2020年に13億4,800万米ドルであったのに対し、2021年には17億4,200万米ドルを研究開発に投資しました。さらに、Bio-Rad Laboratories Inc.は、2020年の8億30万米ドルに対し、2021年には8億7,960万米ドルを投資しました。このように、企業による研究開発投資の増加は、革新的な細胞分析技術を採用する企業の能力をさらに高め、それによって細胞分析市場の成長を促進しています。
戦略的提携と買収の増加
さまざまな主要市場参入企業が、新しく改良された細胞分析法、ツール、技術を開発するために提携や協力関係を結んでいます。例えば、2022年8月、受賞歴のあるCellDrop Automated Cell CounterのメーカーであるDeNovix Inc.は、分離した核と無傷の細胞を破片から区別できる2つの核カウント専用アプリを開発しました。CellDropシリーズは、画像ベースの自動セルカウンターのラインです。システムには、ライブプレビューと結果の即時レビューのための高精細7インチタッチスクリーンが含まれています。同様に、2022年11月には、フローサイトメーターから得られたデータを用いて、様々な細胞集団からがん細胞や幹細胞などの希少細胞を迅速に同定できるフローサイトメトリーデータ解析クラウドソリューション「SFA-Life Sciences Cloud Platform」の提供を開始しました。これに加え、Thermo Fisher Scientificは2022年3月、細胞療法の開発を可能にすることを目的とした新しい大容量エレクトロポレーションシステムを発表しました。このような技術革新は、今後数年間の細胞分析市場需要を強化すると予想されます。
目次
第1章 序文
第2章 調査範囲と調査手法
- 調査の目的
- ステークホルダー
- データソース
- 一次情報
- 二次情報
- 市場推定
- ボトムアップアプローチ
- トップダウンアプローチ
- 調査手法
第3章 エグゼクティブサマリー
第4章 イントロダクション
- 概要
- 主要業界動向
第5章 世界の細胞分析市場
- 市場概要
- 市場実績
- COVID-19の影響
- 市場予測
第6章 市場内訳：製品別
- フローサイトメトリー製品
- qPCR製品
- 細胞マイクロアレイ
- 顕微鏡
- 分光光度計
- 細胞カウンター
- HCSシステム
- その他
第7章 市場内訳：分析タイプ別
- 細胞識別
- 細胞生存率
- 細胞シグナル伝達経路/シグナル伝達
- 細胞増殖
- 細胞計数と品質管理
- 細胞相互作用
- 対象の識別と検証
- 単一細胞解析
- その他
第8章 市場内訳：分析手法別
- 分子アプローチ
- 画像ベースのアプローチ
第9章 市場内訳：エンドユーザー別
- 製薬・バイオテクノロジー企業とCRO
- 病院と診断ラボ
- 研究機関
- 細胞培養コレクションリポジトリ
- その他
第10章 市場内訳：地域別
- 北米
- 米国
- カナダ
- アジア太平洋
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- インドネシア
- その他
- 欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- ロシア
- その他
- ラテンアメリカ
- ブラジル
- メキシコ
- その他
- 中東・アフリカ
- 市場動向
- 市場内訳：国別
- 市場予測
第11章 SWOT分析
- 概要
- 強み
- 弱み
- 機会
- 脅威
第12章 バリューチェーン分析
第13章 ポーターのファイブフォース分析
- 概要
- 買い手の交渉力
- 供給企業の交渉力
- 競合の程度
- 新規参入業者の脅威
- 代替品の脅威
第14章 競合情勢
- 市場構造
- 主要企業
- 主要企業のプロファイル
- Agilent Technologies Inc.
- BD Biosciences
- Bio-RAD Laboratories Inc.
- Danaher Corporation
- Illumina Inc.
- Merck KGaA
- Miltenyi Biotec
- Olympus Corporation
- PerkinElmer Inc.
- Promega Corporation
- Sysmex Corporation
- Thermo Fisher Scientific
List of Figures
- Figure 1: Global: Cell Analysis Market: Major Drivers and Challenges
- Figure 2: Global: Cell Analysis Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Cell Analysis Market: Breakup by Product (in %), 2023
- Figure 4: Global: Cell Analysis Market: Breakup by Analysis Type (in %), 2023
- Figure 5: Global: Cell Analysis Market: Breakup by Techniques (in %), 2023
- Figure 6: Global: Cell Analysis Market: Breakup by End-User (in %), 2023
- Figure 7: Global: Cell Analysis Market: Breakup by Region (in %), 2023
- Figure 8: Global: Cell Analysis Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 9: Global: Cell Analysis (Flow Cytometry Products) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 10: Global: Cell Analysis (Flow Cytometry Products) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 11: Global: Cell Analysis (qPCR Products) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 12: Global: Cell Analysis (qPCR Products) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 13: Global: Cell Analysis (Cell Microarrays) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 14: Global: Cell Analysis (Cell Microarrays) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 15: Global: Cell Analysis (Microscopes) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 16: Global: Cell Analysis (Microscopes) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 17: Global: Cell Analysis (Spectrophotometers) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 18: Global: Cell Analysis (Spectrophotometers) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 19: Global: Cell Analysis (Cell Counters) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 20: Global: Cell Analysis (Cell Counters) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 21: Global: Cell Analysis (HCS Systems) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 22: Global: Cell Analysis (HCS Systems) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 23: Global: Cell Analysis (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 24: Global: Cell Analysis (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 25: Global: Cell Analysis (Cell Identification) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 26: Global: Cell Analysis (Cell Identification) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 27: Global: Cell Analysis (Cell Viability) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 28: Global: Cell Analysis (Cell Viability) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 29: Global: Cell Analysis (Cell Signaling Pathways/Signal Transduction) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 30: Global: Cell Analysis (Cell Signaling Pathways/Signal Transduction) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 31: Global: Cell Analysis (Cell Proliferation) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 32: Global: Cell Analysis (Cell Proliferation) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 33: Global: Cell Analysis (Cell Counting and Quality Control) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 34: Global: Cell Analysis (Cell Counting and Quality Control) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 35: Global: Cell Analysis (Cell Interaction) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 36: Global: Cell Analysis (Cell Interaction) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 37: Global: Cell Analysis (Target Identification and Validation) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 38: Global: Cell Analysis (Target Identification and Validation) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 39: Global: Cell Analysis (Single-Cell Analysis) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 40: Global: Cell Analysis (Single-Cell Analysis) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 41: Global: Cell Analysis (Other Analysis Types) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 42: Global: Cell Analysis (Other Analysis Types) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 43: Global: Cell Analysis (Molecular Approaches) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 44: Global: Cell Analysis (Molecular Approaches) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 45: Global: Cell Analysis (Image-Based Approaches) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 46: Global: Cell Analysis (Image-Based Approaches) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 47: Global: Cell Analysis (Pharmaceutical and Biotechnology Companies and CROs) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 48: Global: Cell Analysis (Pharmaceutical and Biotechnology Companies and CROs) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 49: Global: Cell Analysis (Hospitals and Diagnostic Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 50: Global: Cell Analysis (Hospitals and Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 51: Global: Cell Analysis (Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 52: Global: Cell Analysis (Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 53: Global: Cell Analysis (Cell Culture Collection Repositories) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 54: Global: Cell Analysis (Cell Culture Collection Repositories) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 55: Global: Cell Analysis (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 56: Global: Cell Analysis (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 57: North America: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
- Figure 58: North America: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 59: United States: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
- Figure 60: United States: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 61: Canada: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
- Figure 62: Canada: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 63: Asia Pacific: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
- Figure 64: Asia Pacific: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 65: China: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
- Figure 66: China: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 67: Japan: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
- Figure 68: Japan: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 69: India: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
- Figure 70: India: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 71: South Korea: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
- Figure 72: South Korea: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 73: Australia: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
- Figure 74: Australia: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 75: Indonesia: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
- Figure 76: Indonesia: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 77: Others: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
- Figure 78: Others: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 79: Europe: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
- Figure 80: Europe: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 81: Germany: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
- Figure 82: Germany: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 83: France: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
- Figure 84: France: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 85: United Kingdom: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
- Figure 86: United Kingdom: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 87: Italy: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
- Figure 88: Italy: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 89: Spain: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
- Figure 90: Spain: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 91: Russia: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
- Figure 92: Russia: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 93: Others: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
- Figure 94: Others: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 95: Latin America: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
- Figure 96: Latin America: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 97: Brazil: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
- Figure 98: Brazil: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 99: Mexico: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
- Figure 100: Mexico: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 101: Others: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
- Figure 102: Others: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 103: Middle East and Africa: Cell Analysis Market: Sales Value (in Million US$), 2018 & 2023
- Figure 104: Middle East and Africa: Cell Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 105: Global: Cell Analysis Industry: SWOT Analysis
- Figure 106: Global: Cell Analysis Industry: Value Chain Analysis
- Figure 107: Global: Cell Analysis Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Cell Analysis Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Cell Analysis Market Forecast: Breakup by Product (in Million US$), 2024-2032
- Table 3: Global: Cell Analysis Market Forecast: Breakup by Analysis Type (in Million US$), 2024-2032
- Table 4: Global: Cell Analysis Market Forecast: Breakup by Techniques (in Million US$), 2024-2032
- Table 5: Global: Cell Analysis Market Forecast: Breakup by End-User (in Million US$), 2024-2032
- Table 6: Global: Cell Analysis Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 7: Global: Cell Analysis Market: Competitive Structure
- Table 8: Global: Cell Analysis Market: Key Players
The global cell analysis market size reached US$ 20.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 40.1 Billion by 2032, exhibiting a growth rate (CAGR) of 7.4% during 2024-2032. The shift towards personalized medicine, increasing cases of cancer across the globe, and growing integration of artificial intelligence and machine learning in cell analysis are some of the key factors, catalyzing the growth of the market.
Cell Analysis Market Analysis:
Major Market Drivers: Increasing demand for cell analysis tools in drug discovery and development, particularly in fields like oncology and immunology, is primarily driving the market growth. The rising prevalence of chronic diseases like cancer and autoimmune disorders is augmenting the need for advanced cell analysis techniques for disease diagnosis and treatment, which is also contributing to the market growth.
Key Market Trends: The expansion of regenerative medicine and stem cell research is augmenting the need for cell analysis tools to study cell behavior, differentiation, and therapeutic applications, which is creating a positive outlook for the overall market.
Competitive Landscape: Some of the leading cell analysis companies operating in the global market include Agilent Technologies Inc., BD Biosciences, Bio-RAD Laboratories Inc., Danaher Corporation, Illumina Inc., Merck KGaA, Miltenyi Biotec, Olympus Corporation, PerkinElmer Inc., Promega Corporation, Sysmex Corporation, and Thermo Fisher Scientific, among others.
Geographical Trends: According to the report, North America currently dominates the global market. The growth of the region can be attributed to the increase in incidences of cancer and rising corporate and government funding in cell-based research activities.
Challenges and Opportunities: Challenges include the complexity of interpreting large-scale data, maintaining cell viability during analysis, and the high cost of advanced technologies. Opportunities lie in expanding applications in personalized medicines, regenerative therapies, and the integration of artificial intelligence to enhance analytical capabilities and streamline processes.
Global Cell Analysis Market Trends:
Growing Burden of Cancer
The rising number of cancer cases across the world is primarily driving the market growth. Cell analysis tools and techniques in cancer research enable precise characterization of tumor cells, including their genetic mutations, protein expression profiles, and cellular interactions within the tumor microenvironment. The growing number of cancer patients is catalyzing the cell analysis market share. For instance, as per an American Cancer Society 2022 update, around 1,918,030 new cancer cases were estimated in the U.S. in 2022. Furthermore, lung cancer and breast cancer are two of the most common cancers found among individuals. The Canadian Cancer Society (CCS) stated that in 2020, nearly 29,800 Canadians were diagnosed with lung cancer, which accounted for 13% of all new cancer cases. About 21,200 Canadians were expected to die from lung cancer, which represented 25% of all cancer deaths in 2020. This indicates an inflating need for effective and more advanced cancer cell analysis. Thus, the increasing demand for effective and lasting cancer treatment is anticipated to offer lucrative growth opportunities to the overall market.
Increasing Development of Novel Molecules
The rising prevalence of various infectious diseases is prompting the development of novel molecules and vaccines, which in turn is augmenting the cell analysis market revenue. Cell analysis tools play a crucial role in drug discovery and development by enabling researchers to assess the efficacy, safety, and mechanism of action of potential drug candidates. Furthermore, various pharmaceutical and biotech firms are increasingly relying on cell analysis techniques and tools to introduce new and improved drugs. For instance, according to the data published by the Congressional Budget Office, in 2021, it was observed that pharmaceutical industries spent nearly US$ 200 Billion on research and development in 2020 globally, compared to US$ 83 Million in 2019. Similarly, Danaher Corporation invested US$ 1,742 million in its research and development in 2021, as compared to US$ 1,348 Million in 2020. In addition, Bio-Rad Laboratories Inc., invested US$ 879.6 Million in 2021 as compared to US$ 800.3 Million in 2020. Thus, the rising investment in research and development by the companies further increases the capabilities of the company to adopt innovative cell analysis techniques, thereby propelling the cell analysis market growth.
Rising Number of Strategic Collaborations and Acquisitions
Various key market players are forming partnerships and collaborations to develop new and improved cell analysis methods, tools, and techniques. For instance, in August 2022, DeNovix Inc., the manufacturer of the award-winning CellDrop Automated Cell Counter, developed two dedicated nuclei counting apps capable of differentiating isolated nuclei and intact cells from debris. The CellDrop Series is a line of image-based, automated cell counters. Systems include a high-definition 7-inch touchscreen for live preview and instant review of results. Similarly, in November 2022, Sony Corporation launched the SFA - Life Sciences Cloud Platform, a flow cytometry data analysis cloud solution that can quickly identify rare cells, such as cancer cells and stem cells, from a wide variety of cell populations, using data obtained from flow cytometers. In addition to this, in March 2022, Thermo Fisher Scientific introduced a new large-volume electroporation system that is intended to enable the development of cell therapies. Such innovations are expected to bolster the cell analysis market demand in the coming years.
Global Cell Analysis Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global cell analysis market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product, analysis type, techniques, and end-user.
Breakup by Product:
Flow Cytometry Products
qPCR Products
Cell Microarrays
Microscopes
Spectrophotometers
Cell Counters
HCS Systems
Others
Flow cytometry products exhibit a clear dominance in the market
The cell analysis market report has provided a detailed breakup and analysis of the market based on the product. This includes flow cytometry products, qPCR Products, cell microarrays, microscopes, spectrophotometers, cell counters, HCS systems, and others. According to the report, flow cytometry products exhibit a clear dominance in the market.
Flow cytometry products are pivotal in the cell analysis market, offering precise quantification and characterization of cells based on their physical and chemical properties. Key components include flow cytometers, which analyze cells in fluid suspension using lasers to detect fluorescently labeled cells. Reagents such as fluorescent dyes and antibodies enable specific labeling for biomarker detection, while software facilitates data analysis and visualization. These products are essential in research, clinical diagnostics, and drug discovery, providing insights into cell function, differentiation, and disease mechanisms. Ongoing advancements in technology are enhancing sensitivity, multiplexing capabilities, and automation, expanding the utility of flow cytometry in diverse biomedical applications.
Breakup by Analysis Type:
Cell Identification
Cell Viability
Cell Signaling Pathways/Signal Transduction
Cell Proliferation
Cell Counting and Quality Control
Cell Interaction
Target Identification and Validation
Single-Cell Analysis
Others
Cell identification analysis type holds the majority of the total market share
The cell analysis market research report has provided a detailed breakup and analysis of the market based on the analysis type. This includes cell identification, cell viability, cell signaling pathways/signal transduction, cell proliferation, cell counting and quality control, cell interaction, target identification and validation, single-cell analysis, and others. According to the report, cell identification analysis type holds the majority of the total market share.
Cell identification in cell analysis involves various techniques to distinguish and classify cells based on their morphological, molecular, or functional characteristics. Methods include microscopy for visual inspection, flow cytometry for quantitative analysis of cell surface markers, and molecular techniques like PCR for genetic profiling. Immunohistochemistry and immunofluorescence enable detection of specific proteins within tissues or cell samples. Advances in single-cell analysis technologies allow for high-resolution characterization of individual cells within heterogeneous populations. Accurate cell identification is crucial in understanding disease mechanisms, assessing treatment responses, and advancing personalized medicine by tailoring therapies based on individual cell profiles.
Breakup by Techniques:
Molecular Approaches
Image-Based Approaches
Molecular approaches represent the largest market share
The report has provided a detailed breakup and analysis of the market based on the techniques. This includes molecular approaches and image-based approaches. According to the report, molecular approaches represent the largest market share.
Molecular approaches in cell analysis focus on studying cellular components at the molecular level to understand biological processes and diseases. Techniques include PCR (Polymerase Chain Reaction) for amplifying and detecting DNA or RNA sequences, Western blotting for protein detection and quantification, and next-generation sequencing (NGS) for comprehensive genomic analysis. These methods enable researchers to investigate gene expression, mutations, protein interactions, and epigenetic modifications within cells. Molecular approaches are vital in biomarker discovery, drug development, and personalized medicine, offering insights into cellular function and disease mechanisms with high sensitivity and specificity. Continued advancements enhance their utility in diverse biomedical research applications.
Breakup by End-User:
Pharmaceutical and Biotechnology Companies and CROs
Hospitals and Diagnostic Laboratories
Research Institutes
Cell Culture Collection Repositories
Others
Pharmaceutical and biotechnology companies and CROs currently account for the majority of the total market share
The report has provided a detailed breakup and analysis of the market based on the end-user. This includes pharmaceutical and biotechnology companies and CROs, hospitals and diagnostic laboratories, research institutes, cell culture collection repositories, and others. According to the report, pharmaceutical and biotechnology companies and CROs currently account for the majority of the total market share.
Pharmaceutical and biotechnology companies develop and commercialize drugs and therapies for medical use. They conduct extensive research and clinical trials to discover new compounds, validate their efficacy and safety, and obtain regulatory approvals. Contract Research Organizations (CROs) support these efforts by providing specialized, such as clinical trial management, data analysis, and regulatory compliance. CROs enable companies to outsource non-core activities, accelerate timelines, and manage costs effectively. Furthermore, the increasing rate of new drug development is also contributing to the segment's growth. For instance, between 2010 and 2019, around 38 new drugs were approved each year, on an average. That is about a 60% increase compared with the previous decade. Drug approvals reached a new peak in 2018, surpassing the record number of approvals of the late 1990s. The cell analysis market statistics by IMARC indicate that together, pharmaceutical/biotech firms and CROs are playing crucial roles in advancing healthcare innovation, bringing new treatments to market, and improving patient outcomes through rigorous scientific research and development.
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America currently dominates the global market
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America currently dominates the global market.
The growth of the region can be attributed to the increase in incidences of cancer and rising corporate and government funding in cell-based research. For instance, according to the Canadian Cancer Statistics 2022 Special Report, the number of people living with and after cancer in Canada continued to grow to over 1.5 million people. Additionally, according to another report, 2 in 5 Canadians are expected to be diagnosed with cancer in their lifetime. Approximately 1 in 4 Canadians is expected to die of the disease. Besides this, the presence of major companies, the growing number of product launches, and the strong R&D in biotechnology are further positively impacting the cell analysis market outlook. For instance, in September 2022, Becton, Dickinson, and Company launched BD Research Cloud, a cloud-based software solution designed to streamline the flow cytometry workflow to enable higher-quality experiments with faster time to insight for scientists working across a range of disciplines, including immunology, virology, oncology, and infectious disease monitoring.
Competitive Landscape:
The competitive landscape of the industry has also been examined with the detailed profiles of the following key players:
Agilent Technologies Inc.
BD Biosciences
Bio-RAD Laboratories Inc.
Danaher Corporation
Illumina Inc.
Merck KGaA
Miltenyi Biotec
Olympus Corporation
PerkinElmer Inc.
Promega Corporation
Sysmex Corporation
Thermo Fisher Scientific
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
Global Cell Analysis Market News:
June 2024: Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, announced the launch of the ddSEQ(TM) Single-Cell 3' RNA-Seq Kit and complementary Omnition v1.1 analysis software for single-cell transcriptome and gene expression research.
March 2024: US-headquartered Cytek Biosciences, Inc., opened a new 50,000-square-foot facility in Wuxi, China. This strategic move increases the company's manufacturing capacity to meet the growing worldwide demand for comprehensive cell analysis solutions.
February 2024: 10x Genomics, Inc., a leader in single-cell and spatial biology, announced the launch of GEM-X, the next generation of the company's leading single-cell technology. GEM-X is built on a new and improved microfluidic chip design, featuring the latest technological advancements and optimized reagents for superior performance and high reliability.
Key Questions Answered in This Report
- 1. What was the size of the global cell analysis market in 2023?
- 2. What is the expected growth rate of the global cell analysis market during 2024-2032?
- 3. What are the key factors driving the global cell analysis market?
- 4. What has been the impact of COVID-19 on the global cell analysis market?
- 5. What is the breakup of the global cell analysis market based on the product?
- 6. What is the breakup of the global cell analysis market based on the analysis type?
- 7. What is the breakup of the global cell analysis market based on the techniques?
- 8. What is the breakup of the global cell analysis market based on the end-user?
- 9. What are the key regions in the global cell analysis market?
- 10. Who are the key players/companies in the global cell analysis market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Cell Analysis Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Flow Cytometry Products
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 qPCR Products
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Cell Microarrays
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Microscopes
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Spectrophotometers
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
- 6.6 Cell Counters
- 6.6.1 Market Trends
- 6.6.2 Market Forecast
- 6.7 HCS Systems
- 6.7.1 Market Trends
- 6.7.2 Market Forecast
- 6.8 Others
- 6.8.1 Market Trends
- 6.8.2 Market Forecast
7 Market Breakup by Analysis Type
- 7.1 Cell Identification
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Cell Viability
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Cell Signaling Pathways/Signal Transduction
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Cell Proliferation
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Cell Counting and Quality Control
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 Cell Interaction
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
- 7.7 Target Identification and Validation
- 7.7.1 Market Trends
- 7.7.2 Market Forecast
- 7.8 Single-Cell Analysis
- 7.8.1 Market Trends
- 7.8.2 Market Forecast
- 7.9 Others
- 7.9.1 Market Trends
- 7.9.2 Market Forecast
8 Market Breakup by Techniques
- 8.1 Molecular Approaches
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Image-Based Approaches
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
9 Market Breakup by End-User
- 9.1 Pharmaceutical and Biotechnology Companies and CROs
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Hospitals and Diagnostic Laboratories
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Research Institutes
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Cell Culture Collection Repositories
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
- 9.5 Others
- 9.5.1 Market Trends
- 9.5.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Agilent Technologies Inc.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 BD Biosciences
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 Bio-RAD Laboratories Inc.
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Danaher Corporation
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 Illumina Inc.
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.6 Merck KGaA
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Miltenyi Biotec
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.8 Olympus Corporation
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 PerkinElmer Inc.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Promega Corporation
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.11 Sysmex Corporation
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.11.4 SWOT Analysis
- 14.3.12 Thermo Fisher Scientific
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.12.3 Financials
- 14.3.12.4 SWOT Analysis
- 14.3.1 Agilent Technologies Inc.
